A winning combination: Genomics and deep phenotyping for accelerated drug discovery
from Genetic Engineering & Biotechnology News
Drug discovery and development is such an arduous process; it typically takes more than a decade to achieve a single approval. But researchers can save a lot of time by just starting with optimal targets. One powerful new approach gaining favor is to combine next-generation sequencing and disease phenotyping. So much of this data is now available that truly population-scale projects can be done.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063